
Soligenix fell 74.9% from $1.36 to $0.34, behind the S&P 500's +10.5%. Its worst day was Apr 28 (−70.3%), and its low came May 11 at $0.28.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Soligenix closed at its highest level of the year, 21.3% above where the year started.
+1.2% · S&P 500 −1.1%
EPS of $-0.29 missed the $-0.27 estimate on $0.00 revenue.
+6.3% · S&P 500 +2.9%
Story events cover the past 12 months · Times ET
Soligenix shares fell 70.3%, while the S&P 500 fell 0.5%.
−70.3%, the year's worst day · S&P 500 −0.5%
EPS of $-0.28 missed the $-0.25 estimate on $0.00 revenue.
−4.9% · S&P 500 +0.8%
Soligenix shares surged 72.32% in after-hours trading following rapid Bundibugyo virus vaccine development announcement.
+68.8%, the year's best day, on 247M shares, the year's heaviest volume · S&P 500 0.0%
EPS of $-0.12 beat the $-0.12 estimate on $0.00 revenue.
+3.5% · S&P 500 +0.6%
EPS of $-0.05 beat the $-0.10 estimate on $0.00 revenue.
+0.6% · S&P 500 +0.3%
Where it ended: a close of $0.34 on Nov 9, 2026.
Nothing in the past 12 months.
All SNGX analyst actionsNothing in the past 12 months.
All SNGX dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SNGX and SPY from Benzinga historical bars. Not investment advice.